Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1359 ARTÍCULOS , VIENDO DEL 556 AL 570

Effects of AZD3480 on cognition in patients with mild-to-moderate Alzheimer's disease: a phase IIb dose-finding study

Frölich L, Ashwood T, Nilsson J, Eckerwall G; Sirocco Investigators.

J Alzheimers Dis. 2011;24(2):363-74. doi: 10.3233/JAD-2011-101554.

[Efficacy of cognitive training programs based on new software technologies in patients with Alzheimer-type dementia]

Fernández-Calvo B, Rodríguez-Pérez R, Contador I, Rubio-Santorum A, Ramos F.

Psicothema. 2011 Feb;23(1):44-50.

Fast and robust extraction of hippocampus from MR images for diagnostics of Alzheimer's disease

Lötjönen J, Wolz R, Koikkalainen J, Julkunen V, Thurfjell L, Lundqvist R, Waldemar G, Soininen H, Rueckert D; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2011 May 1;56(1):185-96. doi: 10.1016/j.neuroimage.2011.01.062. Epub 2011 Jan 31.

Young children in early-onset Alzheimer's disease families: research gaps and emerging service needs

Gelman CR, Greer C.

Am J Alzheimers Dis Other Demen. 2011 Feb;26(1):29-35. doi: 10.1177/1533317510391241.

Impact of rivastigmine patch and capsules on activities of daily living in Alzheimer's disease

Grossberg G, Meng X, Olin JT.

Am J Alzheimers Dis Other Demen. 2011 Feb;26(1):65-71. doi: 10.1177/1533317510391240.

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of Alzheimer's disease and other dementias

Ihl R, Frölich L, Winblad B, Schneider L, Burns A, Möller HJ; WFSBP Task Force on Treatment Guidelines for Alzheimer's Disease and other Dementias.

World J Biol Psychiatry. 2011 Feb;12(1):2-32. doi: 10.3109/15622975.2010.538083.

Revisiting the cholinergic hypothesis of behavioral and psychological symptoms in dementia of the Alzheimer's type

Pinto T, Lanctôt KL, Herrmann N.

Ageing Res Rev. 2011 Sep;10(4):404-12. doi: 10.1016/j.arr.2011.01.003. Epub 2011 Feb 1.

"Lest we forget you--methylene blue..."

Schirmer RH, Adler H, Pickhardt M, Mandelkow E.

Neurobiol Aging. 2011 Dec;32(12):2325.e7-16. doi: 10.1016/j.neurobiolaging.2010.12.012. Epub 2011 Feb 12.

Three postulates to help identify the cause of Alzheimer's disease

de la Torre JC.

J Alzheimers Dis. 2011;24(4):657-68. doi: 10.3233/JAD-2011-101884.

Replication of BIN1 association with Alzheimer's disease and evaluation of genetic interactions

Carrasquillo MM, Belbin O, Hunter TA, Ma L, Bisceglio GD, Zou F, Crook JE, Pankratz VS, Sando SB, Aasly JO, Barcikowska M, Wszolek ZK, Dickson DW, Graff-Radford NR, Petersen RC, Morgan K, Younkin SG.

J Alzheimers Dis. 2011;24(4):751-8. doi: 10.3233/JAD-2011-101932.

Managing cognitive dysfunction through the continuum of Alzheimer's disease: role of pharmacotherapy

Delrieu J, Piau A, Caillaud C, Voisin T, Vellas B.

CNS Drugs. 2011 Mar;25(3):213-26. doi: 10.2165/11539810-000000000-00000.

Cognitive activity for the treatment of older adults with mild Alzheimer's disease (AD)--PACE AD: study protocol for a randomised controlled trial

Vidovich MR, Shaw J, Flicker L, Almeida OP.

Trials. 2011 Feb 17;12:47. doi: 10.1186/1745-6215-12-47.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias